Category: Research

As part of our commitment to increasing survival and halving the harm of brain tumours, we have committed over £1 million to transformative research

Our scientists in Heidelberg and London have discovered what drives the unpredictable growth of low grade brain tumours

Hundreds more brain tumour patients are set to be offered access to experimental treatments over the next five years thanks to the Tessa Jowell BRAIN-MATRIX

Researchers have discovered a new drug could potentially halt the spread of glioblastoma cells

Researchers have found a way to monitor diffuse midline gliomas (formerly known as DIPG) by measuring tumour biomarkers through a blood test

Scientists identify a subgroup of children diagnosed with medulloblastoma that could be given less aggressive treatments

Recent research has found that a single signalling pathway regulates the growth and spread of Group 3 medulloblastomas

Tocagen, a clinical-stage, cancer-selective gene therapy company, recently announced that it has completed patient enrolment approximately three months ahead of schedule for their Toca 5 Phase 3 clinical trial

A team of researchers have identified a new therapeutic target in glioblastoma cells that could halt the aggressive growth of this tumour type

Laboratory experiments show that a synthetic chemical is able to shut off glioblastoma cells’ energy source, leading to cell death

Our Research Communications Assistant, Arshiya, gives an overview of the International Symposium on Paediatric Neuro-Oncology (ISPNO)

Researchers from the Institute of Cancer Research discovered that tumour cells in paediatric high-grade gliomas work together to invade other structures of the brain

Results from a phase 1 clinical trial show that patients with recurrent glioblastoma treated with an inactive version of the polio virus live longer than those receiving standard treatment

New data presented at the recent American Association of Clinical Oncology (ASCO) meeting in Chicago by Abbvie, a pharmaceutical company, provides hope for those diagnosed with a glioblastoma

The research engagement team recently visited The Blizard Institute of Cell and Molecular Science in London and met with Dr Tom Millner

A study led by researchers from Duke Cancer Institute identifies genetic markers to classify previously undetermined glioblastomas

Early findings from a phase 3 clinical trial testing DCVax®-L, a dendritic cell treatment, show increased overall survival for patients with glioblastoma.

Recent clinical data reports that a new surgical approach could improve survival for individuals with difficult to access high-grade gliomas

The new bank, announced today, will support and accelerate new research into brain cancer therapy

Researchers have identified a difference between low-grade and high-grade brain tumours that could help develop better treatments for more aggressive forms of the disease.

Results from a phase 1 clinical trial of the oncolytic virus DNX-2401, report successful intratumoral delivery of the virus in children with diffuse midline glioma

A research team of engineers and physicians at Washington University have developed a way to identify brain tumour biomarkers through a blood test

We are delighted to announce that we have joined forces with Cancer Research UK to create an unprecedented £18m fund for research into all aspects of brain tumours

Are you aged 16-17, in full time education, and would like to gain experience working in a laboratory focusing on research into brain tumours? Do you know someone who is?